Our Ambition
Context and
challenge
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, affecting millions annually. Despite medical advancements, significant challenges persist in early detection, diagnosis, and care coordination.
Empower
Our goal is to improve patient outcomes
GRACE aims to address these critical gaps through scalable and sustainable solutions based on AI-drive diagnostics, remote monitoring, and innovative care pathways. Our goal is to improve patient outcomes, optimize healthcare workforce efficiency, and reduce costs.
Key Objectives
Assess the continuum of care for CVDs
Develop and validate comprehensive methods to evaluate and improve patient care pathways.
Integrate sustainable and scalable multimodal interventions
Utilize AI-driven diagnostics, personalized patient monitoring, and advanced therapeutic approaches.
Evaluate the societal impact of GRACE
Measure the direct and indirect benefits of our solutions for patients, healthcare workers, and caregivers.
Assess the economic aspects of implemented solutions
Quantify improvements in healthcare efficiency, cost reduction, and resource optimization.
Develop a scalability and sustainability plan
Ensure that our reference model for cardiovascular care pathways can be adapted and expanded across diverse healthcare systems.
Expected impact
Enhanced clinical pathways
Smarter clinical pathways for heart disease treatment, making healthcare more efficient and user-centered, which will lead to improved patient outcomes.
Patient-Centered care
Patients will benefit from personalized healthcare approaches, leading to better detection, diagnosis, and management of heart disease across the care pathway.
Support for healthcare professionals
Healthcare workers will gain access to novel diagnostic procedures and optimized workflows, enhancing clinical outcomes and improving overall healthcare delivery.
Research and innovation
GRACE will contribute to the academic and industry research on heart disease treatment, developing new personalized methodologies validated across multiple countries.
Cost-effectiveness
The project will analyze and report on the cost-effectiveness of its interventions compared to traditional treatments, ultimately reducing operational costs in healthcare.
Benefits
Technological
platform
By integrating Artificial Intelligence, advanced analytics, and telemedicine, the platform serves as the backbone of the project, ensuring a seamless, data-driven approach to cardiovascular healthcare. It will act as a unifying ecosystem where healthcare providers, patients, and researchers can interact, share data, and access innovative tools for diagnosis, treatment, and long-term patient monitoring.
The primary goal of the GRACE digital platform is to create an interoperable, AI-driven healthcare system that enhances clinical decision-making, improves patient outcomes, and optimizes resource utilization across healthcare networks. It aims to:
Centralize clinical data
From various sources into a single secure system, ensuring interoperability with existing electronic health records (EHR).
Provide AI-driven decision
To assist clinicians in early detection and intervention of cardiovascular diseases.
Enable real-time remote patient monitoring
Integrating wearable technology for continuous health tracking outside the hospital.
Serve as a digital marketplace
Where healthcare institutions can access and deploy validated cardiovascular health solutions